Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
IL3-M82Q7 | Mouse | Biotinylated Mouse IL-33 Protein, His,Avitag™ (MALS verified) |
|
||
IL3-H82H5 | Human | Biotinylated Human IL-33 Protein, His,Avitag™ (MALS verified) |
|
||
IL3-M5245 | Mouse | Mouse IL-33 Protein, His Tag |
|
||
IL3-C5245 | Cynomolgus | Cynomolgus IL-33 Protein, His Tag (MALS verified) |
|
||
IL3-H52H7 | Human | Human IL-33 Protein, His Tag (HPLC verified) |
|
Loaded Human IL-1RL1, Fc Tag (Cat. No. IL1-H5250) on Protein A Biosensor, can bind with Biotinylated Human IL-33, His,Avitag (Cat. No. IL3-H82H5) an affinity constant of 1.81 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Tozorakimab | MEDI-3506 | Phase 3 Clinical | Medimmune | Pneumonia, Viral; Diabetic Nephropathies; Asthma; Pulmonary Disease, Chronic Obstructive; Bronchitis, Chronic; Dermatitis, Atopic | Details |
Itepekimab | REGN-3500; SAR-440340 | Phase 3 Clinical | Sanofi | Bronchiectasis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
Etokimab | ANB-020 | Phase 2 Clinical | Anaptysbio Inc | Pulmonary Eosinophilia; Asthma; Sinusitis; Peanut Hypersensitivity; Hypersensitivity; Dermatitis, Atopic | Details |
MT-2990 | MT-2990 | Phase 2 Clinical | Mitsubishi Tanabe Pharma Corp | Pain; Rhinitis, Allergic, Seasonal; Vasculitis; Endometriosis | Details |
PF-07264660 | PF-07264660 | Phase 2 Clinical | Pfizer Inc | Dermatitis, Atopic | Details |
PF-06817024 | PF-06817024 | Phase 1 Clinical | Pfizer Inc | Nose Diseases; Dermatitis, Atopic | Details |
SSGJ-621 | SSGJ-621; 621 | Phase 1 Clinical | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
CAN-10 | CAN-10 | Phase 1 Clinical | Lund University Foundation | Scleroderma, Systemic; Psoriasis; Myocarditis; Plaque psoriasis | Details |
Torudokimab | LY-3375880 | Phase 1 Clinical | Eli Lilly And Company | Dermatitis, Atopic | Details |
GSK-3862995 | GSK-3862995; GSK3862995; GSK3862995B; GSK-3862995B | Phase 1 Clinical | Glaxosmithkline Plc | Pulmonary Disease, Chronic Obstructive | Details |
QX-007N | QX-007N | Phase 1 Clinical | Qyuns Therapeutics Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
Tozorakimab | MEDI-3506 | Phase 3 Clinical | Medimmune | Pneumonia, Viral; Diabetic Nephropathies; Asthma; Pulmonary Disease, Chronic Obstructive; Bronchitis, Chronic; Dermatitis, Atopic | Details |
Itepekimab | REGN-3500; SAR-440340 | Phase 3 Clinical | Sanofi | Bronchiectasis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
Etokimab | ANB-020 | Phase 2 Clinical | Anaptysbio Inc | Pulmonary Eosinophilia; Asthma; Sinusitis; Peanut Hypersensitivity; Hypersensitivity; Dermatitis, Atopic | Details |
MT-2990 | MT-2990 | Phase 2 Clinical | Mitsubishi Tanabe Pharma Corp | Pain; Rhinitis, Allergic, Seasonal; Vasculitis; Endometriosis | Details |
PF-07264660 | PF-07264660 | Phase 2 Clinical | Pfizer Inc | Dermatitis, Atopic | Details |
PF-06817024 | PF-06817024 | Phase 1 Clinical | Pfizer Inc | Nose Diseases; Dermatitis, Atopic | Details |
SSGJ-621 | SSGJ-621; 621 | Phase 1 Clinical | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
CAN-10 | CAN-10 | Phase 1 Clinical | Lund University Foundation | Scleroderma, Systemic; Psoriasis; Myocarditis; Plaque psoriasis | Details |
Torudokimab | LY-3375880 | Phase 1 Clinical | Eli Lilly And Company | Dermatitis, Atopic | Details |
GSK-3862995 | GSK-3862995; GSK3862995; GSK3862995B; GSK-3862995B | Phase 1 Clinical | Glaxosmithkline Plc | Pulmonary Disease, Chronic Obstructive | Details |
QX-007N | QX-007N | Phase 1 Clinical | Qyuns Therapeutics Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
This web search service is supported by Google Inc.